Healthcare sector team

Analysts

Dr Nathaniel Calloway

Dr Nathaniel Calloway
Associate Healthcare Analyst

Dr Philippa Gardner

Dr Philippa Gardner
Healthcare Analyst

Lala Gregorek

Lala Gregorek
Director of Healthcare Research and Strategy

Pooya Hemami

Pooya Hemami
Analyst

Dr Dennis Hulme

Dr Dennis Hulme
Analyst

Maxim Jacobs

Maxim Jacobs
Director of Healthcare Research, North America

Dr Susie Jana

Dr Susie Jana
Analyst

Dr Jonas Peciulis

Dr Jonas Peciulis
Analyst

Dr Linda Pomeroy

Dr Linda Pomeroy
Analyst

Dr John Savin

Dr John Savin
Analyst

Juan Pedro Serrate

Juan Pedro Serrate
Associate Analyst

Dr Daniel Wilkinson

Dr Daniel Wilkinson
Analyst

By region

Recent initiations

Arix Bioscience Formycon
Collplant Holdings Nuevolution
Xbrane Biopharma LifeWatch

Recent QuickViews

aap Implantate

Time to capitalise on its core focus - trauma

Pharmaceutical & healthcare | published 06/04/2017
Novacyt

Innovative clinical diagnostics

Pharmaceutical & healthcare | published 21/03/2017
Smith & Nephew

All parts now in place to move forward

Pharmaceutical & healthcare | published 14/02/2017
Nuevolution

Delivering on promises

Pharmaceutical & healthcare | published 04/01/2017

Would you like to be notified when new research is published? Access our research RSS feed

Latest research

International Stem Cell

Dosing of first cohort complete

Update | Pharmaceutical & healthcare | 27/04/2017

International Stem Cell recently announced that the first cohort of four patients in its Phase I trial in Parkinson’s disease (PD) had successfully…

Akari Therapeutics

Suspension of Coverage

Update | Pharmaceutical & healthcare | 27/04/2017

Whilst following Edison’s normal publication process, which includes a review of a note by a supervisory analyst and a fact checking of the document…

Medigene

Becoming an increasingly prominent player

Outlook | Pharmaceutical & healthcare | 24/04/2017

Medigene is well funded (FY16 cash €52.6m) to advance both its DC vaccine programmes and TCR programme. We expect a number of important milestones…

Vernalis

FDA issues CCP-07 complete response letter

Update | Pharmaceutical & healthcare | 24/04/2017

FDA has issued a complete response letter (CRL) to Vernalis’ CCP-07 NDA following its 20 April PDUFA date, outlining questions that need to be addressed…

Tonix Pharmaceuticals

HONOR study up and running

Update | Pharmaceutical & healthcare | 20/04/2017

Tonix Pharmaceuticals has commenced enrolment for the Phase III HONOR study of TNX-102 SL in military-related post-traumatic stress disorder (PTSD). It…

Sector commentary

See more reports See more reports See more reports

Sector reports

See more sector reports See more sector reports See more sector reports

Sectors covered

Pharmaceutical & healthcare Show companies